You are here

Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Nagoya-city Naka-ku, Aichi-prefecture, Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pelvic Inflammatory Disease
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
16-80 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Both of following symptoms should be observed.

- Lower abdominal pain and/or lower abdominal tenderness.

- Hypochondrial pain and/or hypochondrial tenderness (tenderness of uterus or adnexa of
uterus).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Known or suspected hypersensitivity or intolerance to azithromycin, other macrolides, or
ketolides.

Hepatic dysfunction (AST, ALT, total bilirubin > 3 times institutional normal).

NCT00871494
Pfizer
Completed
Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now